21 results
8-K
EX-99.1
CMRA
Comera Life Sciences Holdings, Inc.
9 Nov 23
Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights
4:31pm
on the Regeneron project during the three months ending September 30, 2023.
R&D expenses totaled $366 thousand for the three months ended September
8-K
EX-99.1
CMRA
Comera Life Sciences Holdings, Inc.
10 Aug 23
Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights
5:30pm
related to an increase in research activities performed under customer contracts, which had more favorable margins compared with the prior period.
R&D expense
8-K
EX-99.1
CMRA
Comera Life Sciences Holdings, Inc.
12 May 23
Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights
4:31pm
activities performed under customer contracts.
R&D expenses totaled $344 thousand for the three months ended March 31, 2023, compared to $487 thousand
424B3
CMRA
Comera Life Sciences Holdings, Inc.
31 Mar 23
Prospectus supplement
4:34pm
loss carryforward
R&D credit carryforward
Capitalized R&D
Accruals and reserves
Lease liability
Stock-based compensation
Total deferred tax assets
424B3
CMRA
Comera Life Sciences Holdings, Inc.
31 Mar 23
Prospectus supplement
4:34pm
,
Total deferred tax assets:
Federal net operating loss carryforward
R&D credit carryforward
Capitalized R&D
Accruals and reserves
Lease liability
Stock
424B3
edw3 8k2j
31 Mar 23
Prospectus supplement
4:32pm
8-K
EX-99.1
2zs3qpf
10 Nov 22
Comera Life Sciences Reports Financial Results for Third Quarter 2022 and Business Highlights
4:32pm
424B3
j59o1
15 Sep 22
Prospectus supplement
4:09pm
424B3
xwjkhkcn9 4o
2 Sep 22
Prospectus supplement
9:37pm
8-K
EX-99.1
mq4e7hb dhk6oq4j
2 Sep 22
Other Events
9:32pm
424B3
0vix15vugwz
28 Jun 22
Prospectus supplement
10:45am
S-1
vyylockk4tj u36gy1
4 May 22
IPO registration
9:23pm
424B3
i7msxg7k vp
15 Apr 22
Prospectus supplement
11:45am
S-4/A
9qkldmvme87
25 Mar 22
Registration of securities issued in business combination transactions (amended)
5:17pm
S-4
9alrg7ybz9ycx5se
8 Mar 22
Registration of securities issued in business combination transactions
9:49pm